HIV, AIDS and Trump
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Advancements in medicine and public health strategies continue to reshape the HIV landscape. The future of prevention lies in expanding access to innovative treatment options and developing new ...
The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...
A man who took part in a clinical trial for the development of a Covid vaccine is still returning 'false positive' HIV test results. The man, who chose to remain anonymous due to concerns about ...
Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...
A Brisbane man who took part in the University of Queensland’s aborted Covid vaccine trial is still returning “false positive” HIV tests four years later.
Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback